E
ME Therapeutics Holdings Inc. METX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Net Income 12.81% 20.98% 91.85% -278.72% -737.67%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -27.24% -38.31% -94.81% 48.98% 2,624.56%
Change in Net Operating Assets 92.68% -163.46% 127.52% 80.28% -1,161.54%
Cash from Operations 45.63% -44.91% 3.05% -712.09% -505.61%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -106.34% -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 36.21% -1,147.27% -49.94% 7,998.90% -505.61%
Weiss Ratings